PL175518B1 - Preparat farmaceutyczny do leczenia ostrego bólu drogą blokady czuciowej i sposób wytwarzania preparatu farmaceutycznego - Google Patents

Preparat farmaceutyczny do leczenia ostrego bólu drogą blokady czuciowej i sposób wytwarzania preparatu farmaceutycznego

Info

Publication number
PL175518B1
PL175518B1 PL94312198A PL31219894A PL175518B1 PL 175518 B1 PL175518 B1 PL 175518B1 PL 94312198 A PL94312198 A PL 94312198A PL 31219894 A PL31219894 A PL 31219894A PL 175518 B1 PL175518 B1 PL 175518B1
Authority
PL
Poland
Prior art keywords
ropivacaine
pharmaceutically acceptable
acceptable salt
concentration
weight
Prior art date
Application number
PL94312198A
Other languages
English (en)
Polish (pl)
Other versions
PL312198A1 (en
Inventor
Arne T. Eek
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20390432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL175518(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Publication of PL312198A1 publication Critical patent/PL312198A1/xx
Publication of PL175518B1 publication Critical patent/PL175518B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Insulation, Fastening Of Motor, Generator Windings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Air Conditioning Control Device (AREA)
  • Steroid Compounds (AREA)
  • Electromechanical Clocks (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Particle Accelerators (AREA)
  • Medicinal Preparation (AREA)
PL94312198A 1993-06-28 1994-05-26 Preparat farmaceutyczny do leczenia ostrego bólu drogą blokady czuciowej i sposób wytwarzania preparatu farmaceutycznego PL175518B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use
PCT/SE1994/000496 WO1995000148A1 (en) 1993-06-28 1994-05-26 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade

Publications (2)

Publication Number Publication Date
PL312198A1 PL312198A1 (en) 1996-04-01
PL175518B1 true PL175518B1 (pl) 1999-01-29

Family

ID=20390432

Family Applications (1)

Application Number Title Priority Date Filing Date
PL94312198A PL175518B1 (pl) 1993-06-28 1994-05-26 Preparat farmaceutyczny do leczenia ostrego bólu drogą blokady czuciowej i sposób wytwarzania preparatu farmaceutycznego

Country Status (32)

Country Link
US (2) US5670524A (enExample)
EP (1) EP0706395B1 (enExample)
JP (1) JP3725541B2 (enExample)
CN (1) CN1074918C (enExample)
AT (1) ATE216237T1 (enExample)
BR (1) BR9406865A (enExample)
CA (1) CA2165446C (enExample)
CZ (1) CZ283300B6 (enExample)
DE (2) DE706395T1 (enExample)
DK (1) DK0706395T3 (enExample)
EE (1) EE03205B1 (enExample)
ES (1) ES2099048T3 (enExample)
FI (1) FI956269L (enExample)
GR (1) GR970300013T1 (enExample)
HU (1) HU218949B (enExample)
IL (1) IL110006A (enExample)
IS (1) IS4174A (enExample)
LT (1) LT3449B (enExample)
LV (1) LV12918B (enExample)
MY (1) MY119360A (enExample)
NO (1) NO955313D0 (enExample)
NZ (1) NZ268110A (enExample)
PH (1) PH31258A (enExample)
PL (1) PL175518B1 (enExample)
PT (1) PT706395E (enExample)
RU (1) RU2152215C1 (enExample)
SA (1) SA94150010B1 (enExample)
SE (1) SE9302218D0 (enExample)
SG (1) SG49078A1 (enExample)
SK (1) SK280111B6 (enExample)
TW (1) TW285640B (enExample)
WO (1) WO1995000148A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
CA2294950C (en) * 1997-07-21 2009-04-07 Darwin Discovery Limited Levobupivacaine and its use
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
WO2009061497A1 (en) 2007-11-07 2009-05-14 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
AU2013257727B2 (en) * 2012-05-10 2016-04-28 Cellixbio Private Limited Compositions and methods for the treatment of local pain
CN104427977B (zh) * 2012-05-10 2018-02-02 佩因拉佛姆有限公司 局部麻醉剂的储库制剂及其制备方法
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
NZ710740A (en) 2013-02-28 2020-06-26 Dermira Inc Glycopyrrolate salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560367B2 (en) * 1983-08-01 1987-04-02 Astra Lakemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use

Also Published As

Publication number Publication date
JPH09500620A (ja) 1997-01-21
CN1074918C (zh) 2001-11-21
EE03205B1 (et) 1999-08-16
GR970300013T1 (en) 1997-05-31
WO1995000148A1 (en) 1995-01-05
CA2165446A1 (en) 1995-01-05
EP0706395A1 (en) 1996-04-17
ES2099048T1 (es) 1997-05-16
NZ268110A (en) 1999-06-29
DE69430427T2 (de) 2002-11-14
DE706395T1 (de) 1997-09-04
PT706395E (pt) 2002-09-30
HU9503692D0 (en) 1996-02-28
FI956269A7 (fi) 1995-12-27
HU218949B (hu) 2001-01-29
LV12918B (en) 2003-03-20
US5834489A (en) 1998-11-10
NO955313L (no) 1995-12-27
CZ283300B6 (cs) 1998-02-18
ATE216237T1 (de) 2002-05-15
FI956269A0 (fi) 1995-12-27
HK1010344A1 (en) 1999-06-17
SK280111B6 (sk) 1999-08-06
PH31258A (en) 1998-06-18
CZ336495A3 (en) 1996-06-12
ES2099048T3 (es) 2002-11-16
IL110006A0 (en) 1994-11-11
BR9406865A (pt) 1996-03-26
IL110006A (en) 1999-01-26
LT3449B (en) 1995-10-25
CA2165446C (en) 2005-07-05
SA94150010B1 (ar) 2006-04-04
RU2152215C1 (ru) 2000-07-10
AU692161B2 (en) 1998-06-04
US5670524A (en) 1997-09-23
SK164695A3 (en) 1996-07-03
TW285640B (enExample) 1996-09-11
LTIP1958A (en) 1995-01-31
IS4174A (is) 1994-12-29
MY119360A (en) 2005-05-31
CN1126435A (zh) 1996-07-10
PL312198A1 (en) 1996-04-01
EP0706395B1 (en) 2002-04-17
AU7086694A (en) 1995-01-17
DE69430427D1 (de) 2002-05-23
NO955313D0 (no) 1995-12-27
JP3725541B2 (ja) 2005-12-14
FI956269L (fi) 1995-12-27
SG49078A1 (en) 1998-05-18
DK0706395T3 (da) 2002-07-22
HUT75115A (en) 1997-04-28
SE9302218D0 (sv) 1993-06-28

Similar Documents

Publication Publication Date Title
Stenseth et al. Epidural morphine for postoperative pain: experience with 1085 patients
EP0149544B1 (en) Pharmaceutical products providing enhanced analgesia
CA2303815A1 (en) N,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of pain
Grass Sufentanil: clinical use as postoperative analgesic—epidural/intrathecal route
Plowman et al. Central nervous system toxicity attributable to epidural ropivacaine hydrochloride
RU2152215C1 (ru) Применение ропивакаина при изготовлении фармацевтического препарата с анальгезирующим действием с минимальной моторной блокадой
EP0236477B1 (en) Use of 6-methylene-6-desoxy-n-cyclopropylmethyl-14-hydroxydihydronormorphine
EP1318801B1 (en) Topical analgesic compositions containing aliphatic polyamines and methods of using same
JPH0358328B2 (enExample)
JPH11511465A (ja) ハロアルキルアミン及び局所麻酔薬製剤並びに反射性交感神経性ジストロフィー（ｒｓｄ）の治療法
JPS6348217A (ja) 麻酔薬組成物
Wong et al. Influence of imipramine and pargyline on the arrhythmogenicity of epinephrine during halothane, enflurane or methoxyflurane anesthesia in dogs
Kumar Perspectives on Local Anesthetics in Medicine
AU692161C (en) Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
DE69133419T2 (de) Verwendung von Adenosin und Adenosinderivaten für Analgesia
US20070060632A1 (en) Lofexidine
US20130338098A1 (en) Topical Analgesic Compositions Containing Aliphatic Polyamines and Methods of Using Same
AU7231291A (en) Use of local anaesthetic agents in the manufacture of pharmaceutical preparations for iontophoresis
HK1010344B (en) Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
WO1997042955A1 (en) Compositions comprising sodium channel activators and local anesthetics
CZ232391A3 (cs) Použití látek s lokálně anestetlckým účinkem pro výrobu farmaceutických prostředků k iontoforéze
IE911793A1 (en) Use of local anaesthetic agents in the manufacture of¹pharmaceutical preparations for iontophoresis
Raksamani et al. A comparison of etidocaine and lidocaine in epidural analgesia for surgery

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20110526